{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:28:20Z","timestamp":1791199700236,"version":"4.2.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/rlu.0000000000000765","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T11:10:18Z","timestamp":1424517018000},"page":"e334-e335","source":"Crossref","is-referenced-by-count":10,"title":["Simultaneous 18F-FDOPA PET\/CT-Guided Biopsy and Radiofrequency Ablation of Recurrent Neuroendocrine Hepatic Metastasis"],"prefix":"10.1097","volume":"40","author":[{"given":"Alessio","family":"Imperiale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Garnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izzie Jacques","family":"Namer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-38-20210204","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2967\/jnumed.113.126896","article-title":"18F-fluorodihydroxyphenylalanine PETCT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.","volume":"55","author":"Imperiale","year":"2014","journal-title":"J Nucl Med"},{"key":"R2-38-20210204","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00259-013-2342-x","article-title":"(18)F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.","volume":"40","author":"Balogova","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-38-20210204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1102\/1470-7330.2012.0026","article-title":"Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice.","volume":"12","author":"Rust","year":"2012","journal-title":"Cancer Imaging"},{"key":"R4-38-20210204","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.tvir.2013.02.014","article-title":"Interventional positron emission tomography computed tomography: state-of-the-art.","volume":"16","author":"Shyn","year":"2013","journal-title":"Tech Vasc Interv Radiol"},{"key":"R5-38-20210204","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00259-012-2263-0","article-title":"The impact of coaxial core biopsy guided by FDG PETCT in oncological patients.","volume":"40","author":"Cerci","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-38-20210204","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00259-010-1524-z","article-title":"PETCT-guided biopsies of metabolically active bone lesions: applications and clinical impact.","volume":"37","author":"Klaeser","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-38-20210204","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.crad.2013.11.013","article-title":"PETCT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20s breath-hold PET acquisition.","volume":"69","author":"Shyn","year":"2004","journal-title":"Clin Radiol"},{"key":"R8-38-20210204","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jvir.2012.02.006","article-title":"Cone-beam CT Fusionnavigation for real-time PET guided biopsies and ablations: a feasibility study.","volume":"23","author":"Abi-Jaoudeh","year":"2012","journal-title":"J Vasc Interv Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000000765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:11:31Z","timestamp":1620972691000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201506000-00038"}},"subtitle":["Further Step Toward a Theranostic Approach"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000000765","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}